天然干扰素局部应用于乳腺肿瘤引起的转移性胸腔积液的治疗。

Giornale italiano di oncologia Pub Date : 1989-04-01
E Terzoli, F Izzo, S Lucatelli, M Ranuzzi
{"title":"天然干扰素局部应用于乳腺肿瘤引起的转移性胸腔积液的治疗。","authors":"E Terzoli,&nbsp;F Izzo,&nbsp;S Lucatelli,&nbsp;M Ranuzzi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The authors intended verifying the effectiveness of natural beta-interferon in the treatment of metastatic pleural effusion from breast's cancer. 24 patient, with an average age of 54, were studied. The objective responses were: 2 Complete Responses, 8 Partial Responses, 6 Stationarity and 5 Progression. The responses seem independent from the association of systemic treatment. Clinical response has been observed in patients with initial pleural effusion less than or equal to 1000 cc.</p>","PeriodicalId":77541,"journal":{"name":"Giornale italiano di oncologia","volume":"9 2-3","pages":"53-7"},"PeriodicalIF":0.0000,"publicationDate":"1989-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Natural beta-interferon for local use in the treatment of metastatic pleural effusion caused by neoplasm of the breast].\",\"authors\":\"E Terzoli,&nbsp;F Izzo,&nbsp;S Lucatelli,&nbsp;M Ranuzzi\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The authors intended verifying the effectiveness of natural beta-interferon in the treatment of metastatic pleural effusion from breast's cancer. 24 patient, with an average age of 54, were studied. The objective responses were: 2 Complete Responses, 8 Partial Responses, 6 Stationarity and 5 Progression. The responses seem independent from the association of systemic treatment. Clinical response has been observed in patients with initial pleural effusion less than or equal to 1000 cc.</p>\",\"PeriodicalId\":77541,\"journal\":{\"name\":\"Giornale italiano di oncologia\",\"volume\":\"9 2-3\",\"pages\":\"53-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Giornale italiano di oncologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale italiano di oncologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

作者打算验证天然干扰素治疗乳腺癌转移性胸腔积液的有效性。研究对象24例,平均年龄54岁。客观反应为:完全反应2个,部分反应8个,平稳性6个,进展性5个。这些反应似乎独立于系统治疗的关联。在最初胸腔积液小于或等于1000cc的患者中观察到临床反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Natural beta-interferon for local use in the treatment of metastatic pleural effusion caused by neoplasm of the breast].

The authors intended verifying the effectiveness of natural beta-interferon in the treatment of metastatic pleural effusion from breast's cancer. 24 patient, with an average age of 54, were studied. The objective responses were: 2 Complete Responses, 8 Partial Responses, 6 Stationarity and 5 Progression. The responses seem independent from the association of systemic treatment. Clinical response has been observed in patients with initial pleural effusion less than or equal to 1000 cc.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信